Featured Articles

41. Mechanical Movement EVokes Increase In Extracellular Vesicle Production 8/17/2022

    We demonstrate a 12-layer cell culture vessel can be used to produce seven trillion high quality EVs from mesenchymal stem cells (MSCs).

42. A Novel Approach To Type 1 Diabetes Treatment 8/2/2022

    With the combination of a viral vector platform and a fixed bed bioreactor platform, a lab is working on a curative gene therapy that could address and possibly reverse T1D's underlying mechanisms.

43. From Bench To Billions: Facilitating Scale-Up Of Adherent Cultures For Cell And Gene Therapies 6/27/2022

    We review what researchers should consider when they are creating a risk-mitigating adherent culture process for cell and gene therapy scale-up.

44. Comparing Gene Transfer Tools: Adeno-Associated Virus And Lentiviral Vectors 6/8/2022

    We review the advantages, disadvantages, and scaling considerations of adeno-associated virus (AAV) and lentivirus (LV) vector gene transfer mechanisms.

45. Cell Suspension Or Adherent Cell Surface: Which Method Is Right For Your Lab? 6/8/2022

    We review what to consider when selecting an adherent or a suspension platform for your cell culture method to achieve the best growing conditions.

46. Exploring What's Possible With Stem Cell Therapies 6/8/2022

    Explore the changing landscape of stem cell research and cell therapy production and read how emerging solutions have facilitated a new era of more effective and efficient workflows.

47. Why Are MSC-EVs Important And How Can You Scale-Up? 5/26/2022

    Read how with more efficient and consistent production methods, researchers will be able to maximize the full potential of EVs for research and therapeutic application.

48. Lessons Learned: An Inside Look At Overcoming Stem Cell Therapy Scale-up 3/10/2022

    Dr. Carolyn Wrightson shares some of the valuable lessons and considerations she and her team learned about stem cell therapy scale-up and optimization.

49. Successfully Creating Master & Working Cell Banks And Drug Product 2/18/2022

    Implementing Corning HYPERStack-36 vessels allowed Waisman Biomanufacturing to provide CMO services to biotech clients within difficult timelines and improve their COGS.

50. Cell Therapy e-Book: A Comprehensive Look At Key Elements Of Cell Production Success 1/27/2022

    This e-book provides an overview of key considerations and technologies for cell therapy production and developing a therapeutic candidate from research scale to clinical or commercial manufacturing.